Sun Pharma

Sun Pharmaceutical Industries Limited, commonly known as Sun Pharma, is a multinational pharmaceutical company based in India. The company was founded in 1983 by Mr. Dilip Shanghvi, and it has since grown into one of the largest pharmaceutical companies in the world. Sun Pharma specializes in the development, manufacturing, and marketing of generic and branded pharmaceuticals, as well as active pharmaceutical ingredients (APIs) and intermediates.

Sun Pharma has a wide range of products that includes drugs for various therapeutic areas such as cardiology, psychiatry, neurology, gastroenterology, and more. The company has a strong presence in emerging markets such as India, Russia, Brazil, and China, as well as developed markets such as the United States, Europe, Canada, and Australia.

In addition to its pharmaceutical business, Sun Pharma also has a presence in the consumer healthcare and over-the-counter (OTC) products segment. The company has a number of subsidiaries and joint ventures that operate in different countries, and it has a strong focus on research and development to bring innovative and effective products to market.

Sun Pharma is committed to ensuring high-quality products and operates in compliance with global regulatory standards. The company has received numerous awards and recognitions for its performance, including being named one of the top 10 pharmaceutical companies in the world by revenue.